Dr Reddys Laboratories Share Price Today - Live Blog for August 06, 2025

Dr Reddys Laboratories Ltd's share price has fallen by -0.35%, a situation worth noting. At present, the stock is trading at ₹1,194.35. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.8300, while the industry PE ratio is 34.7036.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% drop, and it's now trading at ₹1,195.85 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd experienced a substantial 0.26% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,197.95, making it an appealing option for investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.26% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,197.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.07% in its share price, and it currently trades at ₹1,194.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.01% upswing, and it's currently trading at ₹1,194.95 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd plunged by -0.08%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,194.05, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd experienced a -0.05% dip in its share price and is currently trading at ₹1,195.00. The stock has a PE ratio of 17.8300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% drop, and it's now trading at ₹1,196.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd experienced a -0.22% dip in its share price and is currently trading at ₹1,196.40. The stock has a PE ratio of 17.8300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.29% increase and currently trading at ₹1,199.30 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd experienced a -0.13% dip in its share price and is currently trading at ₹1,196.00. The stock has a PE ratio of 17.8300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,196.50. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.31% upswing and is currently trading at ₹1,195.20, indicating strong market sentiment.

After a notable 0.31% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,195.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock of Dr Reddys Laboratories Ltd suffered a -0.18% drop, and it's now trading at ₹1,190.70 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd share price has declined by -0.18%, and it's currently trading at ₹1,190.70. The stock maintains a PE of 17.8300, while the industry PE is 34.7036, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,191.80. The stock has a PE ratio of 17.8300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.47% decrease in its share price, and it is currently trading at ₹1,193.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.8300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.03% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,198.80 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.21% gain, with the share price now at ₹1,201.65. Notably, the stock's PE ratio stands at 17.8300, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.21%, and as of now, it's trading at ₹1,201.65 per share. This upward trajectory is attracting keen interest from investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,201.85 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.06% boost, with the current market value at ₹1,201.85 per share. This surge has not gone unnoticed by investors.

After a notable 0.18% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,201.15. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 1.62% increase and currently trading at ₹1,210.10 per share. This upward trajectory is turning heads in the market.